| Inhibition of the human thioredoxin system: a molecular mechanism of mercury toxicity CML Carvalho, EH Chew, SI Hashemy, J Lu, A Holmgren Journal of Biological Chemistry 283 (18), 11913-11923, 2008 | 542 | 2008 |
| PD-1/PD-L1 blockade as a novel treatment for colorectal cancer N Yaghoubi, A Soltani, K Ghazvini, SM Hassanian, SI Hashemy Biomedicine & pharmacotherapy 110, 312-318, 2019 | 253 | 2019 |
| Regulation of the catalytic activity and structure of human thioredoxin 1 via oxidation and S-nitrosylation of cysteine residues SI Hashemy, A Holmgren Journal of Biological Chemistry 283 (32), 21890-21898, 2008 | 201 | 2008 |
| Motexafin gadolinium, a tumor-selective drug targeting thioredoxin reductase and ribonucleotide reductase SI Hashemy, JS Ungerstedt, FZ Avval, A Holmgren Journal of biological chemistry 281 (16), 10691-10697, 2006 | 199 | 2006 |
| Immunomodulatory, anti-inflammatory, and antioxidant effects of curcumin N Boroumand, S Samarghandian, SI Hashemy Journal of Herbmed Pharmacology 7 (4), 211-219, 2018 | 130 | 2018 |
| Oxidation and S-nitrosylation of cysteines in human cytosolic and mitochondrial glutaredoxins: effects on structure and activity SI Hashemy, C Johansson, C Berndt, CH Lillig, A Holmgren Journal of biological chemistry 282 (19), 14428-14436, 2007 | 124 | 2007 |
| Role of Wnt/β‐catenin signaling regulatory microRNAs in the pathogenesis of colorectal cancer F Rahmani, A Avan, SI Hashemy, SM Hassanian Journal of cellular physiology 233 (2), 811-817, 2018 | 105 | 2018 |
| The thioredoxin system and cancer therapy: a review F Mohammadi, A Soltani, A Ghahremanloo, H Javid, SI Hashemy Cancer Chemotherapy and Pharmacology 84, 925-935, 2019 | 97 | 2019 |
| Leptin-induced signaling pathways in cancer cell migration and invasion A Ghasemi, J Saeidi, M Azimi-Nejad, SI Hashemy Cellular Oncology 42, 243-260, 2019 | 86 | 2019 |
| Recent advances in the clinical development of immune checkpoint blockade therapy A Ghahremanloo, A Soltani, SMS Modaresi, SI Hashemy Cellular Oncology 42, 609-626, 2019 | 76 | 2019 |
| Comparative measurement of ghrelin, leptin, adiponectin, EGF and IGF-1 in breast milk of mothers with overweight/obese and normal-weight infants A Khodabakhshi, M Ghayour-Mobarhan, H Rooki, R Vakili, SI Hashemy, ... European journal of clinical nutrition 69 (5), 614-618, 2015 | 66 | 2015 |
| The emerging role of substance P/neurokinin-1 receptor signaling pathways in growth and development of tumor cells H Javid, F Mohammadi, E Zahiri, SI Hashemy Journal of physiology and biochemistry 75, 415-421, 2019 | 65 | 2019 |
| Leptin induces matrix metalloproteinase 7 expression to promote ovarian cancer cell invasion by activating ERK and JNK pathways A Ghasemi, SI Hashemy, M Aghaei, M Panjehpour Journal of Cellular Biochemistry 119 (2), 2333-2344, 2018 | 54 | 2018 |
| Oxidative stress in cervical cancer pathogenesis and resistance to therapy S Ebrahimi, A Soltani, SI Hashemy Journal of cellular biochemistry 120 (5), 6868-6877, 2019 | 53 | 2019 |
| Oxidative stress factors and C‐reactive protein in patients with oral lichen planus before and 2 weeks after treatment SI Hashemy, S Gharaei, S Vasigh, S Kargozar, B Alirezaei, ... Journal of Oral Pathology & Medicine 45 (1), 35-40, 2016 | 51 | 2016 |
| Evaluation of serum level of substance P and tissue distribution of NK-1 receptor in breast cancer M Davoodian, N Boroumand, M Mehrabi Bahar, AH Jafarian, M Asadi, ... Molecular biology reports 46, 1285-1293, 2019 | 50 | 2019 |
| RhoA/ROCK pathway mediates leptin-induced uPA expression to promote cell invasion in ovarian cancer cells A Ghasemi, SI Hashemy, M Aghaei, M Panjehpour Cellular signalling 32, 104-114, 2017 | 50 | 2017 |
| The role of substance P/neurokinin 1 receptor in the pathogenesis of esophageal squamous cell carcinoma through constitutively active PI3K/Akt/NF-κB signal transduction pathways H Javid, J Asadi, F Zahedi Avval, AR Afshari, SI Hashemy Molecular biology reports 47, 2253-2263, 2020 | 47 | 2020 |
| Substance P accelerates the progression of human esophageal squamous cell carcinoma via MMP-2, MMP-9, VEGF-A, and VEGFR1 overexpression F Mohammadi, H Javid, AR Afshari, B Mashkani, SI Hashemy Molecular biology reports 47, 4263-4272, 2020 | 42 | 2020 |
| Cytokines as potential combination agents with PD‐1/PD‐L1 blockade for cancer treatment G Rahimi Kalateh Shah Mohammad, A Ghahremanloo, A Soltani, E Fathi, ... Journal of Cellular Physiology 235 (7-8), 5449-5460, 2020 | 41 | 2020 |
Hossein JavidPh.D. of Medical Biochemistry, Assistant Professor, Varastegan Institute for Medical SciencesAdresse e-mail validée de varastegan.ac.ir
